ZEO and Pluri Agree to Expand U.S. Regenerative Medicine Platform
ZEO and Pluri entered into a definitive strategic agreement to expand their U.S. manufacturing and commercialization platform. Specific operating terms were not disclosed.
ZEO and Pluri entered into a definitive strategic agreement to expand their U.S. manufacturing and commercialization platform. Specific operating terms were not disclosed.